Europe Artificial Intelligence (AI) in Drug Discovery Market - Industry Trends and Forecast to 2029

Europe Artificial Intelligence (AI) in Drug Discovery Market - Industry Trends and Forecast to 2029

Europe Artificial Intelligence (AI) in drug discovery market is projected to register a substantial CAGR of 52.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029.

Market Segmentation
Europe Artificial Intelligence (AI) in Drug Discovery Market, By Application (Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation & Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug, and Others), Technology (Machine Learning, Deep Learning, Natural Language Processing, and Others), Drug Type (Small Molecule and Large Molecule), Offering (Software and Services.), Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and Others), End Use (Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies, Research Centers and Academic Institutes, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and Rest of Europe) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the Europe Artificial Intelligence (AI) in drug discovery market are:

• Rise in incidence of chronic diseases propels need for AI in drug discovery
• Strategic collaborations, partnerships and products launch

Market Players

The key market players operating in the Europe Artificial Intelligence (AI) in drug discovery market are listed below:

• NVIDIA Corporation
• IBM Corp.
• Atomwise Inc.
• Microsoft
• Envisagenics
• Owkin Inc.
• BERG LLC
• Schrödinger, Inc.
• XtalPi Inc.
• BIOAGE Inc.



Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.